Helius Medical Technologies

Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced ongoing efforts to secure fair market access for its Portable Neuromodulation Stimulator (PoNS) device. Moreover, the company expressed dissatisfaction …

Helius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing Challenges Read More

Panavance Therapeutics

Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism

BERWYN, PA — Panavance Therapeutics Inc. has announced groundbreaking findings this week, demonstrating the potential of their investigational drug, misetionamide (GP-2250), to tackle various forms of cancer by directly inhibiting …

Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism Read More